| scholarly article | Q13442814 |
| P2093 | author name string | J Franco | |
| J Daniel | |||
| S Ho | |||
| D McKee | |||
| J S Bajaj | |||
| R R Varma | |||
| K Saeian | |||
| Midwest Hepatitis Study Group | |||
| C Peine | |||
| J F Knox | |||
| P2860 | cites work | Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial | Q43034904 |
| Factors influencing ribavirin-induced hemolysis | Q43672293 | ||
| Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study | Q43742730 | ||
| Vitamin E for chronic hepatitis B. | Q53809956 | ||
| Vitamin E and its role in the prevention of atherosclerosis and carcinogenesis: a review | Q35190947 | ||
| Once-weekly epoetin alfa improves anemia and facilitates maintenance of ribavirin dosing in hepatitis C virus-infected patients receiving ribavirin plus interferon alfa | Q42981515 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ribavirin | Q421862 |
| P304 | page(s) | 1189-1193 | |
| P577 | publication date | 2004-11-01 | |
| P1433 | published in | Alimentary Pharmacology & Therapeutics | Q4726656 |
| P1476 | title | High-dose vitamin E supplementation does not diminish ribavirin-associated haemolysis in hepatitis C treatment with combination standard alpha-interferon and ribavirin | |
| P478 | volume | 20 |
| Q38060232 | An evidence-based systematic review of vitamin A by the natural standard research collaboration |
| Q24235796 | Antioxidant supplements for liver diseases |
| Q48326289 | Antioxidant vitamins C and E supplementation increases markers of haemolysis in sickle cell anaemia patients: a randomized, double-blind, placebo-controlled trial |
| Q35585469 | Antioxidants as therapeutic agents for liver disease |
| Q33370676 | Complementary treatments of chronic viral hepatitis C |
| Q50571983 | High-dose vitamins E and C supplementation prevents ribavirin-induced hemolytic anemia in patients with chronic hepatitis C. |
| Q35207742 | Impact of pentoxifylline and vitamin e on ribavirin-induced haemolytic anaemia in chronic hepatitis C patients: an egyptian survey |
| Q36316956 | Pathophysiological basis for antioxidant therapy in chronic liver disease |
| Q37195248 | Ribavirin in the treatment of chronic hepatitis C. |
| Q45219626 | Serum oxidative-anti-oxidative stress balance is dysregulated in patients with hepatitis C virus-related hepatocellular carcinoma |
| Q34554574 | The use of selected nutrition supplements and complementary and alternative medicine in liver disease |